Inotiv
CLOSE ×
×

Dechloroethylcyclophosphamide

Inotiv
Analyte
Dechloroethylcyclophosphamide
Species
Human
Matrix
Plasma
Anticoagulant
Heparin
Instrument
LC-MS/MS
Aliquot Volume
200 µl
LLOQ-ULOQ
0.1-10 µg/mL
Storage Temperature
-20 and/or -80°C
Status
Inactive

Examples in Scientific Literature

Fludarabine, cyclophosphamide, and rituximab treatment achieves long-term disease-free survival in IGHV-mutated chronic lymphocytic leukemia

Posttransplantation cyclophosphamide for prevention of graft-versus-host disease after HLA-matched mobilized blood cell transplantation

Human metabolites and transformation products of cyclophosphamide and ifosfamide: analysis, occurrence and formation during abiotic treatments

Tags: autoimmune disease, breast cancer, cell apoptosis, chemotherapy, cyclophosphamide metabolite, DCCP, DNA alkylating agent, immunosuppressant, leukemia, lymphoma, multiple myeloma, neuroblastoma, organ transplant, sarcoma, small cell lung cancer

BASi Method Number SAP.011

Subscribe to updates from Inotiv

Sign up and you’ll receive the latest updates that matter to you, delivered straight to your inbox.

Subscribe now  

Copyright © 2024 Inotiv. All Rights Reserved.